Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE: 603139)
Health Care · Pharmaceuticals · CN
CN¥34.88
-1.58% today · +44.2% 1Y
Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE: 603139) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $518.24M and employs 804 people.
Over the last twelve months the share price has gained 44.2%, trading between 19.91 and 46.92.
Tweenvest scores Shaanxi Kanghui Pharmaceutical Co., Ltd. across four factors: quality 55/100, value 40/100, growth 0/100. Its strongest factor is quality.
603139 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $518.24M
- Revenue (TTM)
- $64.27M
- P/E
- —
- EPS
- -2.97
- Dividend yield
- —
- Beta (5Y)
- 0.56
- 52-week high
- CN¥46.92
- 52-week low
- CN¥19.91
- Avg volume (3M)
- —
- Shares outstanding
- 99.88M
- Employees
- 804
- Next earnings
- —
About Shaanxi Kanghui Pharmaceutical Co., Ltd.
Shaanxi Kanghui Pharmaceutical Co., Ltd. is a Chinese company dedicated to the development, production, and distribution of a wide array of pharmaceutical products. Its comprehensive portfolio includes medications targeting numerous therapeutic areas, such as women's health, orthopedic conditions, dermatological issues, diabetes, respiratory ailments, urinary system disorders, cardiovascular and cerebrovascular diseases, gastrointestinal problems, and hepatobiliary complaints. These drugs are available in various dosage forms, including tablets, capsules, granules, mixtures, teas, plasters, ointments, liniments, lotions, and tinctures. The company's headquarters are situated in Xianyang, China.
- ISIN
- CNE100002XT3
- Founded
- 1999
- Listed since
- Apr 21, 2017
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,239.69 | -1.25% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.54 | +0.48% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $149.86 | -1.76% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.88 | -0.68% |
Figures last refreshed Aug 18, 2026.